Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Chamberlain FE, Wilding C, Jones RL, Huang P. Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. Expert Opin Investig Drugs. 2019 Jun; 28(6):505-511.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Animals
Humans
Indazoles
Liposarcoma
Neoplasm Grading
Protein Kinase Inhibitors
Pyrimidines
Sulfonamides
Treatment Outcome

authors with profiles

Robin Jones